Investigating the impact of CircRNAs on cancer progression and drug resistance

Law­mak­ers in Con­gress are al­leg­ing that the Chi­nese ge­nomics gi­ant BGI set up sub­sidiaries in the US to try and avoid reg­u­la­to­ry and po­lit­i­cal scruti­ny,

Plus, news about On­cono­va Ther­a­peu­tics, Trawsfyny­dd Ther­a­peu­tics, No­cion Ther­a­peu­tics, Gink­go Bioworks and Mod­u­lus Ther­a­peu­tics: Zymeworks ousts CFO: The biotech dis­closed Mon­day that it had re­moved